Document is current
Any future updates will be listed below
-
Authors
Izuhara, Muneto
Matsui, Kentaro
Okubo, Ryo
Yoshiike, Takuya
Nagao, Kentaro
Kawamura, Aoi
Tsuru, Ayumi
Utsumi, Tomohiro
Hazumi, Megumi
Sasaki, Yohei
Takeda, Kazuyoshi
Komaki, Hirofumi
Oi, Hideki
Kim, Yoshiharu
Kuriyama, Kenichi http://orcid.org/0000-0002-0254-4357
Miyama, Takeshi
Nakagome, Kazuyuki
-
Funding
Funding for this research was provided by:
National Center of Neurology and Psychiatry (Reserch Grant 2-1)
- License Information
-
More Information
Article History
Received: 1 September 2023
Accepted: 15 February 2024
First Online: 6 March 2024
Declarations
:
: This study was reviewed and approved by the ethics committee of the NCNP, Tokyo, Japan (approval No. A2020-121). Written informed consent for participation was obtained from all the participants in accordance with the Declaration of Helsinki.
: Not applicable.
: Dr. Izuhara reports personal fees from Eisai outside the submitted work. Dr. Matsui reports personal fees from Eisai, Meiji Seika Pharma, Mochida, MSD, Otsuka Pharmaceutical Co., Ltd., and Yoshitomi Pharmaceutical outside the submitted work. Dr. Yoshiike reports personal fees from MSD and Takeda Pharmaceutical Co. outside the submitted work. Dr. Kawamura reports personal fees from Otsuka Pharmaceutical Co., Ltd. and Takeda Pharmaceutical Co., Ltd. outside the submitted work. Dr. Utsumi reports personal fees from Eisai outside the submitted work. Dr. Nagao reports personal fees from Dainippon Sumitomo and Takeda Pharmaceutical Co., Ltd. outside the submitted work. Dr. Tsuru reports personal fees from MSD outside the submitted work. Dr. Kuriyama reports research grants from Otsuka Pharmaceutical Co., Ltd. and Shionogi Pharma, research grants and personal fees from Meiji Seika Pharma, Eisai, MSD, Takeda Pharmaceutical Co., Ltd., and Tsumura, and personal fees from Yoshitomi Pharmaceutical and Sumitomo Pharma outside the submitted work. Dr. Oi reports research grants outside the submitted work from Otsuka Pharmaceutical Co., Ltd. and Sumitomo Pharma Co., Ltd. Dr. Nakagome reports research grants from SHIONOGI &l Co., Ltd., research grants and personal fees from Sumitomo Pharma, Otsuka Pharmaceutical Co., Meiji-Seika Pharma Co., Ltd., Janssen Pharmaceutical, Mitsubishi Tanabe Pharma Crop., Nippon Boehringer Ingelheim Co., Ltd., and MOCHIDA PHARMACEUTICAL CO., LTD., and personal fees from Takeda Pharmaceutical Co., Ltd., Lundbeck Japan, Viatris, Eisai Co., Ltd., outside the submitted work. There are no other disclosures to report.
